Vaccitech Newsroom

Newsroom

News & updates

Oxford COVID-19 vaccine begins human trial stage

Oxford, UK - Vaccitech announces today that its scientific founders at the Jenner Institute, University of Oxford, have begun testing a COVID-19 vaccine in human volunteers. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half...

Vaccitech to Present at Solebury Trout Virtual Investor Conference

Oxford, UK – 30th March 2020  Vaccitech Ltd, a clinical stage biopharmaceutical company developing immunotherapies to treat infectious diseases and cancer, announced today that its Chief Executive Officer, Bill Enright, will present an update on the Company’s progress...

Vacancy: Clinical Programme Lead

To assist with the coordination and oversight of cross-functional activities to support the Vaccitech portfolio of research and development programmes. All activities carried out within allocated time, and agreed costs in accordance with quality requirements,...

New MERS Coronavirus vaccine clinical trial starts in Saudi Arabia

Vaccitech’s partner, the University of Oxford’s Jenner Institute, in collaboration with The King Abdullah International Medical Research Centre (KAIMRC), announced that it has started a Phase I clinical trial in the Kingdom of Saudi Arabia (KSA) for a vaccine against...